First Stage Investor

NowRx Facing “Unprecedented” Demand

NowRx Facing “Unprecedented” Demand
By Andy Gordon
Date May 18, 2020
Share
When we first recommended NowRx to you in July 2018, its valuation was $20 million. Last November, we recommended you invest in the company again at a $65 million valuation — a more than 3X increase on your original investment price. We were impressed by its execution and…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Sign up today

Top Posts on Early Investing

Crypto Monitor: A Victory for Crypto in China and Hong Kong

China has a complicated relationship with crypto. The Chinese government continues to promote the use and development of blockchain, but crypto trading is still banned in mainland China.…

Bitcoin Decouples From Stocks, Moves Closer to Gold

Crypto Market Musings It’s been a relatively calm week for crypto. Bitcoin is up 1.73% over the last seven days as of this writing. Ethereum is up 3.54%…

New Pick: A Hidden Treasure in the Plant-Based Meat Market

Editor’s Note: This recommendation was co-authored by KingsCrowd Investment Research Manager Olivia Strobl. Mmmm, pizza.